C-type natriuretic peptide in human coronary atherosclerotic lesions

Circulation

Volumn 94, Issue 12, 1996, Pages 3103-3108

  Naruko, Takahiko ^a   Ueda, Makiko ^b   Van der Wal, Allard C ^a   Van der Loos, Chris M ^a   Itoh, Hiroshi ^c   Nakao, Kazuwa ^c   Becker, Anton E ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

atherosclerosis; muscle, smooth; natriuretic peptides

Indexed keywords

NATRIURETIC PEPTIDE TYPE C;

ADULT; AGED; ARTICLE; ATHEROGENESIS; AUTOPSY; CHILD; CORONARY ARTERY ATHEROSCLEROSIS; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PEPTIDE ANALYSIS; PRIORITY JOURNAL;

EID: 0030452795     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.12.3103     Document Type: Article

References (35)

1. De Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 1981;28:89-94.
2. Kangawa K, Matsuo H. Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide. Biochem Biophys Res Commun. 1984;118:131-139.
3. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature (Lond). 1988;332:78-81.
4. Sudoh T, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun. 1990;168:863-870.
5. De Bold AJ. Atrial natriuretic factor: a hormone produced by the heart. Science (Wash DC). 1985;230:767-770.
6. Needleman P, Adams SP, Cole BR, Currie MG, Geller DM, Michener ML, Saper CB, Schwartz D, Standaert DG. Atriopeptins as cardiac hormones. Hypertension. 1985;7:469-482.
7. Rosenzweig A, Seidman CE. Atrial natriuretic factor and related peptide hormones. Annu Rev Biochem. 1991;60:229-255.
8. Nakao K, Ogawa Y, Suga S, Imura H. Molecular biology and biochemistry of the natriuretic system, I: natriuretic peptides. J Hypertens. 1992;10:907-912.
9. Kojima M, Minamino N, Kangawa K, Matsuo H. Cloning and sequence analysis of a cDNA encoding a precursor for rat C-type natriuretic peptide (CNP). FEBS Lett. 1990;276:209-213.
10. Komatsu Y, Nakao K, Suga S, Ogawa Y, Mukoyama M, Arai H, Shirakami G, Hosoda K, Nakagawa O, Hama N, Kishimoto I, Imura H. C-type natriuretic peptide (CNP) in rats and humans. Endocrinology. 1991;129:1104-1106.
11. Ueda S, Minamino N, Aburaya M, Kangawa K, Matsukura S, Matsuo H. Distribution and characterization of immunoreactive porcine C-type natriuretic peptide. Biochem Biophys Res Commun. 1991; 175:759-767.
12. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, Imura H. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-β: possible existence of 'vascular natriuretic peptide system.' J Clin Invest. 1992;90: 1145-1149.
13. Stingo AJ, Clavell AL, Heublein DM, Wei CM, Pittelkow MR, Burnett JC Jr. Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am J Physiol. 1992;263:H1318-H1321.
14. Heublein DM, Clavell AL, Stingo AJ, Lerman A, Wold L, Burnett JC Jr. C-type natriuretic peptide immunoreactivity in human breast vascular endothelial cells. Peptides. 1992;13:1017-1019.
15. Komatsu Y, Nakao K, Itoh H, Suga S, Ogawa Y, Imura H. Vascular natriuretic peptide. Lancet. 1992;340:622. Letter.
16. Ishizaka Y, Kangawa K, Minamino N, Ishii K, Takano S, Eto T, Matsuo H. Isolation and identification of C-type natriuretic peptide in human monocytic cell line, THP-1. Biochem Biophys Res Commun. 1992;189:697-704.
17. Vollmar AM, Schulz R. Expression and differential regulation of natriuretic peptides in mouse macrophages. J Clin Invest. 1995;95: 2442-2450.
18. Furuya M, Takehisa M, Minamitake Y, Kitajima Y, Hayashi Y, Ohnuma N, Ishihara T, Minamino N, Kangawa K, Matsuo H. Novel natriuretic peptide, CNP, potently stimulates cyclic GMP production in rat cultured vascular smooth muscle cells. Biochem Biophys Res Commun. 1990;170:201-208.
19. Furuya M, Yoshida M, Hayashi Y, Ohnuma N, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells. Biochem Biophys Res Commun. 1991;177:927-931.
20. Porter JG, Catalano R, McEnroe G, Lewicki JA, Protter AA. C-type natriuretic peptide inhibits growth factor-dependent DNA synthesis in smooth muscle cells. Am J Physiol. 1992;263:C1001-C1006.
21. Suga S, Itoh H, Komatsu Y, Ogawa Y, Hama N, Yoshimasa T, Nakao K. Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells: evidence for CNP as a novel autocrine/ paracrine regulator from endothelial cells. Endocrinology. 1993;133: 3038-3041.
22. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
23. Harrison DG, Freiman PC, Armstrong ML, Marcus ML, Helstad DD. Alterations of vascular reactivity in atherosclerosis. Circ Res. 1987; 61:1174-1180.
24. Shimokawa H, Vanhoutte PH. Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and in atherosclerosis. Circ Res. 1989;64:900-914.
25. Libby P, Schwartz D, Brogi E, Tanaka H, Clinton SK. A cascade model for restenosis: a special case of atherosclerosis progression. Circulation. 1992;86(suppl III):III-47-III-52.
26. Dzau VJ, Gibbons GH. Vascular remodeling: mechanisms and implications. J Cardiovasc Pharmacol. 1993;21(suppl 1):S1-S5.
27. Raines EW, ROSS R. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br Heart J. 1993;69:S30-S37.
28. Van der Wal AC, Becker AE, van der Loos CM, Tigges AJ, Das PK. Fibrous and lipid-rich atherosclerotic plaques are part of interchangeable morphologies related to inflammation: a concept. Coron Artery Dis. 1994;5:463-469.
29. Hama N, Itoh H, Suga S, Komatsu Y, Yoshimasa T, Nakao K. A monoclonal antibody to C-type natriuretic peptide, preparation and application to radioimmunoassay and neutralization experiment. J Endocrinol 1994;141:473-479.
30. Van der Loos CM, Becker AE, van den Oord JJ. Practical successful immunoenzyme double-staining experiments. Histochem J. 1993;25:1-13.
31. Van der Loos CM, Naruko T, Becker AE. The use of enhanced polymer one-step staining (EPOS) reagents for immunoenzyme double staining. Histochem J. 1996;28:709-714.
32. Furuya M, Aisaka K, Miyazaki T, Honbou N, Kawashima K, Ohno T, Tanaka S, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide inhibits intimal thickening after vascular injury. Biochem Biophys Res Commun. 1993;193:248-253.
33. Shinomiya M, Tashiro J, Saito Y, Yoshida S, Furuya M, Oka N, Tanaka S, Kangawa K, Matsuo H. C-type natriuretic peptide inhibits intimal thickening of rabbit carotid artery after balloon catheter injury. Biochem Biophys Res Commun. 1994;205:1051-1056.
34. Sugiyama S, Kugiyama K, Matsumura T, Suga S, Itoh H, Nakao K, Yasue H. Lipoproteins regulate C-type natriuretic peptide secretion from cultured vascular endothelial cells. Arterioscler Thromb Vasc Biol. 1995;15:1968-1974.
35. Brown J, Chen Q. An autocrine system for C-type natriuretic peptide (CNP) occurs in rat arterial neointima. J Physiol. 1995;489P:139P.